Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Campanacci

Showing results (211-220 of 224) with videos related to

Pageof 23
Sort By:
Journal of Chemotherapy (Florence, Italy)|August 1, 1997
Neoadjuvant chemotherapy for osseous malignant fibrous histiocytoma of the extremity: results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimenG Bacci, S Ferrari, F Bertoni, et al.
La Chirurgia Degli Organi Di Movimento|January 1, 1990
Margins, necrosis and local recurrence after conservative surgery in osteosarcomaP Picci, R Capanna, G Bacci, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1986
Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy?G Bacci, P Picci, F Gherlinzoni, et al.
Cancer Treatment and Research|January 1, 1993
Surgery of osteosarcoma of the extremities: indications and complications in the recent experience at the Istituto Ortopedico RizzoliP Ruggieri, R Biagini, G Bacci, et al.
Oncogene|February 16, 1995
The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuitR Ferracini, M F Di Renzo, K Scotlandi, et al.
The New England Journal of Medicine|November 23, 1995
Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcomeN Baldini, K Scotlandi, G Barbanti-Bròdano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated reportG Bacci, S Ferrari, F Bertoni, et al.
Tumori|August 31, 1989
Giant cell tumor of bone: a model for the in vitro human osteoclast characterizationM Campanacci, G P Bagnara, M Serra, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1989
Centralized diagnosis and treatment of bone and soft tissue tumorsM Campanacci, R Kotz, L Gennari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatinG Bacci, S Ferrari, N Delepine, et al.
Pageof 23

Showing results (211-220 of 224) with videos related to

Sort By:
Pageof 23
Journal of Chemotherapy (Florence, Italy)|August 1, 1997
Neoadjuvant chemotherapy for osseous malignant fibrous histiocytoma of the extremity: results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimenG Bacci, S Ferrari, F Bertoni, et al.
La Chirurgia Degli Organi Di Movimento|January 1, 1990
Margins, necrosis and local recurrence after conservative surgery in osteosarcomaP Picci, R Capanna, G Bacci, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1986
Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy?G Bacci, P Picci, F Gherlinzoni, et al.
Cancer Treatment and Research|January 1, 1993
Surgery of osteosarcoma of the extremities: indications and complications in the recent experience at the Istituto Ortopedico RizzoliP Ruggieri, R Biagini, G Bacci, et al.
Oncogene|February 16, 1995
The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuitR Ferracini, M F Di Renzo, K Scotlandi, et al.
The New England Journal of Medicine|November 23, 1995
Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcomeN Baldini, K Scotlandi, G Barbanti-Bròdano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated reportG Bacci, S Ferrari, F Bertoni, et al.
Tumori|August 31, 1989
Giant cell tumor of bone: a model for the in vitro human osteoclast characterizationM Campanacci, G P Bagnara, M Serra, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1989
Centralized diagnosis and treatment of bone and soft tissue tumorsM Campanacci, R Kotz, L Gennari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatinG Bacci, S Ferrari, N Delepine, et al.
Pageof 23